{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:43:20Z","timestamp":1792496600800,"version":"4.5.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      High\u2010dose dual therapy (HDDT) has been shown to achieve eradication rates non\u2010inferior to the bismuth quadruple therapy (BQT) in treatment\u2010na\u00efve patients of\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">Helicobacter pylori<\/jats:styled-content>\n                        (\n                        <jats:styled-content style=\"fixed-case\">H. pylori<\/jats:styled-content>\n                        )\n                      <\/jats:italic>\n                      infection, with advantages including greater convenience and fewer adverse events. However, the efficacy of different potassium\u2010competitive acid blockers (P\u2010CABs) in HDDT regimens remains incompletely defined due to variations in their pharmacokinetic properties. Therefore, this study aims to evaluate the eradication rates, incidence of adverse events, and compliance of the dual regimens of vonoprazan\/tegoprazan combined with amoxicillin in patients with treatment\u2010na\u00efve\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>H. pylori<\/jats:italic>\n                      <\/jats:styled-content>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This prospective, multicenter, open\u2010label, randomized controlled clinical trial enrolled newly diagnosed patients with H. pylori infection from six centers in China. All subjects were randomly assigned to the VA group (vonoprazan 20\u2009mg bid+amoxicillin 1\u2009g tid, 14\u2009days) or the TA group (tegoprazan 50\u2009mg bid+amoxicillin 1\u2009g tid, 14\u2009days). The basic information and clinical data of the patients were collected via electronic questionnaires, WeChat, or telephone follow\u2010ups. H. pylori eradication was assessed 4\u2009weeks post\u2010treatment using the urea breath test (UBT). The adverse events and compliance were meticulously recorded throughout the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Between June 2024 and May 2025, 710 patients were randomly assigned, and 653 subjects were included. In the intention\u2010to\u2010treat (ITT) analysis, the eradication rates were 89.3% in the VA group and 76.1% in the TA group, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The modified intention\u2010to\u2010treat (mITT) analysis showed rates of 94.6% and 80.8%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and the per\u2010protocol (PP) analysis yielded 95.1% and 81.0%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Although the overall incidence of adverse event rates was comparable between groups (17.2% vs. 13.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.254), gastrointestinal adverse events were less frequent with TA therapy (9.3% vs. 14.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048). Compliance was excellent and comparable in both groups (94.6% vs. 94.1%, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.871). None of the factors analyzed significantly influenced eradication rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Vonoprazan\/amoxicillin dual therapy achieved satisfactory\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>H. pylori<\/jats:italic>\n                      <\/jats:styled-content>\n                      eradication rates with a favorable safety profile in treatment\u2010na\u00efve patients. Tegoprazan\/amoxicillin dual therapy was associated with fewer gastrointestinal adverse event incidences, while optimizing tegoprazan dosing frequency may be necessary to improve the eradication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/chictr.org.cn\">Chictr.org.cn<\/jats:ext-link>\n                      ChiCTR2400082371\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hel.70124","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:11:54Z","timestamp":1775103114000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vonoprazan Versus Tegoprazan\u2013Amoxicillin Dual Therapy for Treatment\u2010Na\u00efve Patients With\n                    <scp>\n                      <i>Helicobacter pylori<\/i>\n                    <\/scp>\n                    Infection: A Prospective, Multicenter, Open\u2010Label, Randomized Controlled Study"],"prefix":"10.1111","volume":"31","author":[{"given":"Ya\u2010Ni","family":"Zhou","sequence":"first","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2010Chun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Chibi General Hospital  Chibi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing\u2010Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology The First People's Hospital of Kunshan  Suzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology First Affiliated Hospital of Soochow University  Suzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wenchang People's Hospital  Wenchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De\u2010Min","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing\u2010Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wuhan Eighth Hospital  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wuhan Eighth Hospital  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2010Ting","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology The First People's Hospital of Kunshan  Suzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wuhan Eighth Hospital  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6300-1460","authenticated-orcid":false,"given":"Pei\u2010Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"},{"name":"Health Management Center Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15751"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.028"},{"issue":"5","key":"e_1_2_11_5_1","first-page":"289","article-title":"Sixth Chinese National Consensus Report on Management of \n                     Helicobacter pylori\n                   Infection(Treatment Excluded)","volume":"42","author":"Helicobacter pylori Study Group, Chinese Society of Gastroenterology,Chinese Medical Association","year":"2022","journal-title":"Chinese Journal of Gastroenterology"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010024\u201003153\u2010w"},{"issue":"2","key":"e_1_2_11_7_1","first-page":"137","article-title":"Research Progress on the Dual Therapy of Amoxicillin and Proton Pump Inhibitors for \n                     Helicobacter pylori\n                   Infection","volume":"42","author":"Han Y. Y.","year":"2022","journal-title":"Chinese Journal of Digestive Surgery"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15917"},{"issue":"11","key":"e_1_2_11_9_1","first-page":"745","article-title":"2022 Chinese National Clinical Practice Guideline on \n                     Helicobacter pylori\n                   Eradication Treatment","volume":"42","author":"Helicobacter pylori Study Group, Chinese Society of Gastroenterology,Chinese Medical Association","year":"2022","journal-title":"Chinese Journal of Gastroenterology"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12940"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003437"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.05.055"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002592"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002968"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12977"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000699"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16798"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1629567"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13151"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710223171717"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12242"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.08.038"},{"issue":"6","key":"e_1_2_11_23_1","first-page":"426","article-title":"The Role and Research Progress of Acid Suppressants in the Treatment of \n                     Helicobacter pylori\n                   Infection","volume":"42","author":"Han Y. Y.","year":"2022","journal-title":"Chinese Journal of Digestive Surgery"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13039"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100975"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043058"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2544886"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15268"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02042-2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0326-7"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1805"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13121"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.170274"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15438"},{"issue":"3","key":"e_1_2_11_35_1","first-page":"301","article-title":"Acid, Protons and \n                     Helicobacter pylori","volume":"69","author":"Sachs G.","year":"1996","journal-title":"Yale Journal of Biology and Medicine"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002714"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060698"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.870817"},{"issue":"7","key":"e_1_2_11_39_1","first-page":"634","article-title":"China Guideline for the Screening, Early Detection and Early Treatment of Gastric Cancer (2022, Beijing)","volume":"44","author":"He J.","year":"2022","journal-title":"Chinese Journal of Oncology"},{"issue":"10","key":"e_1_2_11_40_1","first-page":"5027","article-title":"A Retrospective Study of the Antibiotic\u2010Resistant Phenotypes and Genotypes of \n                     Helicobacter pylori\n                   Strains in China","volume":"11","author":"Zhong Z.","year":"2021","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332640"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251366156"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hel.70124","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hel.70124","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hel.70124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:25:17Z","timestamp":1792495517000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hel.70124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/hel.70124"],"URL":"https:\/\/doi.org\/10.1111\/hel.70124","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70124"}}